The global next generation sequencing market was valued at $13 billion in 2023, and is projected to reach $97.8 billion by 2035, growing at a CAGR of 18.3% from 2024 to 2035.
Report Code : A01718 | Pages : 275 | Category : Life Sciences
The U.S. Pharmacogenomics market size was valued at $2,463.9 Million in 2021, and is projected to reach $5,676.1 Million by 2031, registering a CAGR of 8.7% from 2021 to 2031.
Report Code : A47358 | Pages : 141 | Category : Life Sciences
The South Korea next generation sequencing market was valued at $0.2 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 19.9% from 2024 to 2033.
Report Code : A325432 | Pages : 90 | Category : Life Sciences
The Asia-Pacific next generation sequencing market was valued at $2.5 billion in 2023, and is projected to reach $15.3 billion by 2033, growing at a CAGR of 19.9% from 2024 to 2033.
Report Code : A325431 | Pages : 90 | Category : Life Sciences
